M2 Group Holdings, maker of disposable medical devices used to deliver medication for Type 1 diabetes, has raised $6 million of an anticipated $10 million round of equity, according to regulatory filings. Based in Sunnyvale, Calif., the company has previously been backed by Thomas McNerney & Partners.